From June 29 to 22, CPHI China 2023 returned to Shanghai New International Expo Center (Pudong) after two years of absence. The exhibition, which has built up two years of anticipation for the pharmaceutical industry, st……
From April 22th to 24th, the 88th China International Pharmaceutical API/Intermediates/Packaging/Equipment Trade Fair (API China) was held successfully in Qingdao Expo City International Exhibition Center. The Dorr……
In recent years, Dorra’s business type has expanded and business scale has increased rapidly, the strategic development path of the company is clear, and the upgrading of the company's business model is gradually imp……
Reading a good book is like making a good friend, the longer the time goes by, the deeper the friendship will be.At the end of July, the second phase of the reading and sharing activities has been launched inside of Dorr……
In order to enhance the communication, to promote the growth and to help the integration of new employees, the HR department of Dorra Pharma decided to build a communication platform for everyone, on July 2, Dorra Pharma……
4 April 2020 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Rybelsus? (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabet……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 蘇ICP備12056923號-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
